These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 110327)

  • 21. Interferon inhibits melanogenesis in B-16 mouse melanoma cells.
    Fisher PB; Mufson RA; Weinstein IB
    Biochem Biophys Res Commun; 1981 May; 100(2):823-30. PubMed ID: 6168262
    [No Abstract]   [Full Text] [Related]  

  • 22. alpha-Melanocyte-stimulating hormone binding and biological activity in a human melanoma cell line.
    Legros F; Coel J; Doyen A; Hanson P; Van Tieghem N; Vercammen-Grandjean A; Fruhling J; Lejeune FJ
    Cancer Res; 1981 Apr; 41(4):1539-44. PubMed ID: 6260342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the role of cyclic AMP in the function of skin melanophores.
    Novales RR
    Ann N Y Acad Sci; 1971 Dec; 185():494-506. PubMed ID: 4330514
    [No Abstract]   [Full Text] [Related]  

  • 24. MSH and melanoma cells.
    Lerner AB; Varga JM
    Front Horm Res; 1977; 4():126-8. PubMed ID: 207590
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on peptides. LXXV. Synthesis of the hexadecapeptide corresponding to the entire amino acid sequence of beta-melanocyte-stimulating hormone from the dogfish (Squalus acanthias).
    Yajima H; Iwai J; Koyama K; Nakamura M; Miyata K; Tanaka A
    Chem Pharm Bull (Tokyo); 1978 Feb; 26(2):571-8. PubMed ID: 305829
    [No Abstract]   [Full Text] [Related]  

  • 26. The dual effect of melanocyte-stimulating hormone (MSH) on the growth of cultured mouse melanoma cells.
    Halaban R; Lerner AB
    Exp Cell Res; 1977 Aug; 108(1):111-7. PubMed ID: 196867
    [No Abstract]   [Full Text] [Related]  

  • 27. The amphibian melanocyte: microtubules, cyclic AMP, and organelle translocation.
    Bitensky MW; Keirns CN; Keirns JJ
    Ann N Y Acad Sci; 1975 Jun; 253():685-91. PubMed ID: 167639
    [No Abstract]   [Full Text] [Related]  

  • 28. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.
    Sawyer TK; Sanfilippo PJ; Hruby VJ; Engel MH; Heward CB; Burnett JB; Hadley ME
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5754-8. PubMed ID: 6777774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Synthesis of [D-alanine, 4'-azido-3',5'-ditritio-L-phenylalanine, norvaline4[alpha-melanotropin as a 'photoaffinity probe' for hormone-receptor interactions (author's transl)].
    Eberle A; Schwyzer R
    Helv Chim Acta; 1976 Nov; 59(7):2421-31. PubMed ID: 190192
    [No Abstract]   [Full Text] [Related]  

  • 30. Application of percent labeled mitoses (PLM) analysis to the investigation of melanoma cell responsiveness to MSH stimulation throughout the cell cycle.
    Fuller BB; Brooks BA
    Exp Cell Res; 1980 Mar; 126(1):183-90. PubMed ID: 6766870
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of acute and chronic administration of DDT upon pituitary melanocyte-stimulating hormone (MSH) activity.
    Peaslee MH; Goldman M; Milburn SE
    Comp Gen Pharmacol; 1972 Jun; 3(10):191-4. PubMed ID: 4542435
    [No Abstract]   [Full Text] [Related]  

  • 32. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
    Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
    Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma cells resistant to inhibition of growth by melanocyte stimulating hormone.
    Pawelek J; Sansone M; Koch N; Christie G; Halaban R; Hendee J; Lerner AB; Varga JM
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):951-5. PubMed ID: 165495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-melanocyte-stimulating hormone structure-activity studies: comparative analysis of melanotropic and CNS bioactivities.
    Sawyer TK; Hadley ME; Hruby VJ; Castrucci AM; Staples DJ; Farah J; O'Donohue TL
    Synapse; 1988; 2(3):289-92. PubMed ID: 2850630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioassay of pigmentary hormones.
    Abe K; Nicholson EW
    Methods Enzymol; 1975; 37():121-30. PubMed ID: 165368
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulation of melanocyte stimulating hormone action at the receptor level: discontinuous binding of hormone to synchronized mouse melanoma cells during the cell cycle.
    Varga JM; Dipasquale A; Pawelek J; McGuire JS; Lerner AB
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1590-3. PubMed ID: 4365570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro effects of melanocyte-stimulating hormone, adrenocorticotropic hormone, 17 beta-estradiol, or testosterone propionate on Cloudman S91 mouse melanoma cells.
    Cobb JP; McGrath A
    J Natl Cancer Inst; 1974 Feb; 52(2):567-70. PubMed ID: 4361184
    [No Abstract]   [Full Text] [Related]  

  • 38. Modified in vitro assay for melanocyte-stimulating hormones.
    Kastin AJ; Miller MC; Schally AV
    Experientia; 1969 Feb; 25(2):192-3. PubMed ID: 5786106
    [No Abstract]   [Full Text] [Related]  

  • 39. Small peptides with melanocyte-stimulating activity.
    Medzihradszky K; Medzihradszky-Schweiger H
    FEBS Lett; 1976 Aug; 67(1):45-7. PubMed ID: 182545
    [No Abstract]   [Full Text] [Related]  

  • 40. Hormone--receptor interactions: melanotropic activities of the covalent serum albumin complexes with alpha-melanotropin, alpha-melanotropin fragments, and enkephalin.
    Eberle A; Kriwaczek VM; Schwyzer R
    FEBS Lett; 1977 Aug; 80(2):246-50. PubMed ID: 196929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.